GlobalSpace Technologies Limited has filed its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company’s Board of Directors approved the financial statements during a meeting held on August 14, 2026.

The filing confirms that the reviewed results, along with the limited review report, have been uploaded to the Bombay Stock Exchange (BSE) website for public access. The company did not disclose specific revenue or profit figures in the initial newspaper publication notice, directing investors to the exchange filings for detailed metrics.

Filing Details

The financial results were approved by the Board in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The documents were published in Financial Express and Mumbai Lakshadeep on August 17, 2026.

Krishna Murari Singh, Managing Director, signed off on the disclosure. Investors can access the full financial statement via the QR code provided in the original filing or through the BSE corporate filings section.

Globalspace Technologies Limited's board has approved the acquisition of an additional 99.83% stake in its subsidiary, Miljon Mediapp Private Limited, through the conversion of a loan amounting to ₹12.64 crore into equity shares. The decision, aimed at strengthening control over the pharma-focused digital engagement platform, was taken during a board meeting held on June 18, 2026. The transaction is expected to be completed on or before July 31, 2026.

The acquisition involves converting an existing loan granted by the company into equity, resulting in a total cost of acquisition of ₹12.64 crore. This move is not classified as a related party transaction under Regulation 2(1)(zc) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No regulatory approvals are required for this conversion, which will increase the company's shareholding in Miljon Mediapp to 99.83%.

Miljon Mediapp operates within the Pharma Tech industry, providing a digital engagement ecosystem designed to connect pharmaceutical companies with healthcare professionals, patients, distributors, and field sales teams. The platform facilitates patient support programs, medication adherence initiatives, doctor engagement, and digital detailing. By utilizing real-time analytics and compliant digital workflows, the entity aims to assist pharmaceutical companies in improving therapy adoption and maximizing sales and marketing efficiency.

Financial disclosures regarding the target entity indicate a net worth of ₹31,97,000 as on March 31, 2026. The entity reported nil turnover for the fiscal years 2025-26 and 2024-25. Miljon Mediapp was converted into a company form from a Limited Liability Partnership (LLP) on March 29, 2025.

Acquisition Details